Halozyme Therapeutics shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.2M | 71k | 73.34 |
| 2025-06-30 | $1.9M | 36k | 52.01 |
| 2025-03-31 | $5.7M | 90k | 63.78 |
| 2024-12-31 | $3.4M | 72k | 47.70 |
| 2024-09-30 | $12M | 218k | 57.12 |
| 2024-06-30 | $24M | 453k | 52.35 |
| 2024-03-31 | $33M | 806k | 40.68 |
| 2023-12-31 | $33M | 897k | 36.96 |
| 2023-09-30 | $33M | 861k | 38.20 |
| 2023-06-30 | $43M | 1.2M | 36.07 |
| 2023-03-31 | $27M | 700k | 38.19 |
| 2022-12-31 | $25M | 446k | 56.90 |
| 2022-09-30 | $19M | 487k | 39.54 |
| 2022-06-30 | $264k | 6.0k | 43.98 |
| 2022-03-31 | $7.0k | 193 | 36.27 |
| 2021-12-31 | $127k | 3.2k | 39.97 |
| 2021-09-30 | $103k | 2.5k | 40.58 |
| 2021-06-30 | $122k | 2.7k | 45.19 |
| 2021-03-31 | $104k | 2.5k | 41.57 |
| 2020-12-31 | $86k | 2.0k | 42.53 |
| 2020-09-30 | $53k | 2.0k | 26.21 |
| 2020-06-30 | $4.0M | 151k | 26.81 |
| 2019-12-31 | $44k | 2.5k | 17.45 |
| 2019-09-30 | $7.0k | 464 | 15.09 |